Genital Warts Market Report 2026

Genital Warts Market Overview

• Genital Warts market size has reached to $2.06 billion in 2025 • Expected to grow to $2.65 billion in 2030 at a compound annual growth rate (CAGR) of 5.1% • Growth Driver: Rising Sexually Transmitted Infection (STI) Rates Propel Growth In Genital Warts Market • Market Trend: Innovative Dermatology Drugs For Genital Warts • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Genital Warts Market?

Genital warts refer to condylomata acuminata, which are sexually transmitted infections (STI) caused by certain strains of the human papillomavirus (HPV). These warts typically appear as small growths or clusters of bumps on or around the genital and anal areas and vary in size and shape, may be raised or flat, and often have a cauliflower-like appearance. Genital warts are usually painless but can cause itching, discomfort, or bleeding during sexual intercourse. The main types of drugs for genital warts are imiquimod, podophyllin, podofilox, and trichloroacetic acid. Imiquimod refers to a topical cream that stimulates the immune system to fight genital warts caused by HPV. The different treatments include chemical treatment, ablative treatment, preventive treatment, and other treatments. The genders include females and males and are used by different end users, such as hospitals, clinics, and home care settings.

What Is The Genital Warts Market Growth Forecast?

The genital warts market size is expected to see strong growth in the next few years. It will grow to $2.65 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increased hpv vaccination coverage, development of novel topical agents, expansion of outpatient treatments, early screening initiatives, patient preference for non-invasive care. Major trends in the forecast period include rising adoption of topical treatment therapies, increasing awareness of hpv-related infections, growing demand for minimally invasive ablative treatments, expansion of preventive hpv vaccination programs, increased use of home-based treatment options.

Global Genital Warts Market Segmentation

1) By Drug Type: Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid 2) By Treatment: Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments 3) By Gender: Female, Male 4) By End Users: Hospitals, Clinics, Home Care Settings Subsegments: 1) By Imiquimod: Imiquimod Cream 5%, Imiquimod Cream 3.75% 2) By Podophyllin: Podophyllin Resin 10%, Podophyllin Resin 25% 3) By Podofilox: Podofilox Gel 0.5%, Podofilox Solution 0.5% 4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%, Trichloroacetic Acid 50-70%

What Is The Driver Of The Genital Warts Market?

The increasing prevalence of sexually transmitted infections (STIs) propels the growth of the genital warts market going forward. Sexually transmitted infections (STIs) are infections that are primarily transmitted through sexual contact, including vaginal, anal, and oral sex, and are caused by bacteria, viruses, or parasites. The prevalence of sexually transmitted infections is growing due to increased sexual activity, inadequate use of protection, and limited access to education and healthcare services. Genital warts are a common sexually transmitted infection (STI) caused by specific strains of the human papillomavirus (HPV). They spread through direct skin-to-skin contact during sexual activity. For instance, in September 2025, according to the Centers for Disease Control and Prevention, a US-based government public health agency, reported that in 2024, more than 2.2 million cases of chlamydia, gonorrhea, and syphilis were reported. Therefore, the increasing prevalence of sexually transmitted infections (STIs) is driving the growth of the genital warts industry.

Key Players In The Global Genital Warts Market

Major companies operating in the genital warts market are Merck & Co. Inc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, ANI Pharmaceuticals Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ Global AB, Cassiopea Inc, GlaxoSmithKline plc, Pfizer Inc, Bayer AG, Astellas Pharma Inc, Amgen Inc, Boehringer Ingelheim, Johnson & Johnson, Eli Lilly and Company, Novan Inc

Global Genital Warts Market Trends and Insights

Major companies operating in the genital warts market are developing novel treatment options, such as novel dermatology drugs, to address the challenges faced by patients with genital warts. Dermatology drugs refer to newly developed pharmaceuticals or therapeutic agents specifically designed to treat various dermatologic conditions, such as genital warts. For instance, in March 2023, Verrica Pharmaceuticals Inc., a US-based dermatology pharmaceutical company, received New Chemical Entity (NCE) status for its drug candidate YCANTH. YCANTH is being developed to treat genital warts and has completed phase 2 trials. With FDA NCE status, the company now has at least five years of protection from generic competition.

What Are Latest Mergers And Acquisitions In The Genital Warts Market?

In April 2024, Endo, Inc., a US-based generics and specialty-branded pharmaceutical company, acquired Endo International plc for an undisclosed amount. Through this acquisition, Endo, Inc. aims to strengthen its portfolio of both generic and specialty pharmaceuticals, enhancing its capacity to serve patients and healthcare providers. Endo International plc, a US-based generics and specialty-branded pharmaceutical company.

Regional Outlook

North America was the largest region in the genital warts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genital Warts Market?

The genital warts market consists of revenues earned by entities by providing services such as medical consultations, diagnostic testing, treatment procedures, follow-up care, and patient education programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The genital warts market also includes sales of topical treatments, cryotherapy devices, surgical instruments, immune response modifiers, and antiviral medications. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Genital Warts Market Report 2026?

The genital warts market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the genital warts industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.